$35M QVAR Inhaler Settlement Resolves Teva Pharmaceuticals Antitrust Lawsuit
May 6, 2026 A $35M QVAR settlement ends a class action lawsuit that alleges Teva illegally sought to block competition for its inhaler products.
May 6, 2026 A $35M QVAR settlement ends a class action lawsuit that alleges Teva illegally sought to block competition for its inhaler products.
March 4, 2026 An antitrust class action lawsuit alleges that UFC has monopolized the MMA market, forcing fans to pay inflated prices to stream live events.